Health Economics &
Market Access

Pricing and access strategy (PICO, pricing, national and regional stakeholder mapping, among others), pre-IPTs, and mandatory regulatory documents (value dossier, budget impact analysis, and GINF guidelines). Economic evaluation of health technologies (cost minimization, cost-effectiveness/utility/benefit), and tools for facilitating the access of medicines and medical devices to the Spanish National Health System at national, regional, and local levels.

Strategic consulting in pricing policies, reimbursement processes, health technology assessment (HTA), pharmacoeconomics, and comprehensive market access planning. In-company training on the use of tools developed.

Global communication plan, including launch events, panel discussions, omnichannel strategies, social media campaigns, press releases, media impacts, etc.